Sun Pharma rises on acquiring 14 prescription brands from Novartis in Japan for $293 million

30 Mar 2016 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 807.45, up by 13.40 points or 1.69% from its previous closing of Rs. 794.05 on the BSE.

The scrip opened at Rs. 812.00 and has touched a high and low of Rs. 815.00 and Rs. 805.95 respectively. So far 29,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.70 on 07-Apr-2015 and a 52 week low of Rs. 706.40 on 24-Nov-2015.

Last one week high and low of the scrip stood at Rs. 850.00 and Rs. 770.80 respectively. The current market cap of the company is Rs. 1,93,977.48 crore.

The promoters holding in the company stood at 54.97% while Institutions and Non-Institutions held 35.25% and 9.77% respectively.

Sun Pharmaceutical Industries has entered the Japanese prescription market with the acquisition of 14 established prescription brands from Novartis AG and Novartis Pharma AG (Novartis) in Japan. According to the agreements entered into between the parties, a wholly-owned subsidiary of Sun Pharma will acquire the portfolio consisting of 14 established prescription brands from Novartis for a cash consideration of $293 million. These brands have combined annualized revenues of approximately $160 million and address medical conditions across several therapeutic areas.

Under the terms of the agreements, Novartis will continue to distribute these brands, for a certain period, pending transfer of all marketing authorizations to Sun Pharma’s subsidiary. The acquired brands will be marketed by a reliable and established local marketing partner under the Sun Pharma label. The local marketing partner will also be responsible for distribution of the brands.

Sun Pharma is the world’s fifth largest specialty generic pharmaceutical company and India’s top pharmaceutical company. Its global presence is supported by 49 manufacturing facilities spread across 6 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities.


Sun Pharma Inds. Share Price

1673.55 4.35 (0.26%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×